Deep Biopsy Via Endoscopic Submucosal Dissection in Upper GI Subepithelial Tumors
This trial is active, not recruiting.
|Conditions||benign neoplasm, pathology|
|Treatment||deep biopsy via esd technique|
|Sponsor||Hanyang University Seoul Hospital|
|Start date||May 2010|
|End date||April 2013|
|Trial size||40 participants|
|Trial identifier||NCT01993199, deep biopsy111|
Upper gastrointestinal subepithelial tumors are frequently encountered during esophagogastroduodenoscopy. Treatment plans for subepithelial tumors are determined by algorithms based on endoscopic ultrasonography images. However, endoscopic ultrasonography alone may not be able to diagnose and evaluate upper gastrointestinal SETs with sufficient accuracy. Adequate tissue samples are required to increase the diagnostic accuracy of subepithelial tumors.
Deep biopsy is method that normal mucosa was dissected using enodsocpi submucosal dissection technique and multiple endoscopic biopsies were performed.
The investigators will perform deep biopsy in subepithelial tumor.
|Intervention model||single group assignment|
the number of pathologic diagnosis of deep biopsy
time frame: within the 7 day
Male or female participants of any age.
Inclusion Criteria: - patients with upper GI SETs Exclusion Criteria: - none
|Official title||Prospective Study: Deep Biopsy Via Endoscopic Submucosal Dissection in Upper GI Subepithelial Tumors|
Call for more information